Principal Display Panel – 10 mL Carton Label (Pot0w 0004 01)
Potassium Chloride
Product Images NDC 14789-137
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 14789-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nexus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel – 10 mL Vial Label (Pot0w 0004 02)
NDC 14789-136-07 is a prescription medication that contains potassium chloride. Each milliliter (mL) of the medication contains 2 milliequivalents (mEq) or 149 milligrams (mg) of potassium chloride. The medication is a sterile, nonpyrogenic solution for injection. It has an osmolality of 4 milliosmoles per milliliter (mOsmol/m) when calculated. The usual dosage should be seen in the insert provided. Any unused portion of the concentrate should be discarded. The medication does not contain more than a certain amount (unspecified) and must be diluted with 100 milliequivalents per liter (mieg/L) before use. The medication is manufactured in the USA by NEXUS and is in a 10 mL single-dose vial. It is intended for intravenous use. The address of the manufacturer is located in Lincolnshire, IL 60069, USA.*
Principal Display Panel – 20 mL Carton Label (Pot0w 0004 03)
Principal Display Panel – 20 mL Vial Label (Pot0w 0004 04)
This text is a description for a medication labeled NDC 14789-137-07. It is recommended for prescription use only. The medication contains potassium chloride in each milliliter, specifically 2 milliequivalents or 149 milligrams. It may also contain hydrochloric acid for pH adjustment. The text emphasizes that the medication must be diluted before use. It is described as a sterile and nonpyrogenic injection concentrate, with a concentration of 4 milliosmoles per milliliter. The usual dosage is specified as 40 milliequivalents per 20 milliliters (2 milliequivalents per milliliter). The unused portion should be discarded according to the insert provided. The medication claims to contain no more than 100 micrograms per liter of aluminum. It is created in the United States by Nexus Pharmaceuticals Inc. and is packaged in a 20 mL single-dose vial. The medication is intended for intravenous use. The company's address is mentioned as Lincolnshire, IL 60069, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
